K-H Heider

9 papers receiving 524 citations

Peers

K-H Heider
Comparison fields: 5 of 54
  • Immunology and Allergy 123
  • Cell Biology 278
  • Oncology 199
  • Molecular Biology 331
  • Immunology 81
Replace Motoshige Higashiyama with:
Motoshige Higashiyama Japan
K C Gatter United Kingdom
Khashayar Lessan United Kingdom
Keisuke Iihara Japan
Luciano Zardi Italy
Kei Matsuda United States
Taher E.I. Taher Netherlands
R. Arch Germany
Johanna Soikkeli Finland
Douglas Boyd United States
K-H Heider relative to Motoshige Higashiyama Japan Motoshige Higashiyama's profile →
Citations per field
00.5×
Motoshige Higashiyama · 1×
Citations per year

Countries citing papers authored by K-H Heider

Since Specialization
Citations

This map shows the geographic impact of K-H Heider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K-H Heider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K-H Heider more than expected).

Fields of papers citing papers by K-H Heider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K-H Heider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K-H Heider. The network helps show where K-H Heider may publish in the future.

Co-authors

The 25 scholars most cited alongside K-H Heider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K-H Heider Line = papers co-authored together K-H Heider links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 1995327
2 199667
3 201753
4
Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
199926
5 199620
6
CD44 splice variants: expression during lymphocyte activation and tumor progression.
199317
7 199811
8 199510
9 20021

About K-H Heider

K-H Heider is a scholar working on Immunology and Allergy, Cell Biology, Immunology, Biotechnology and Oncology, having authored 9 papers that have together received 532 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cell Adhesion Molecules Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Galectins and Cancer Biology (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Immunology and Allergy (123 citations), Cell Biology (278 citations), Oncology (199 citations), Molecular Biology (331 citations) and Immunology (81 citations). K-H Heider has collaborated with scholars based in Germany, Austria and Netherlands. Frequent co-authors include Peter Herrlich, Helmut Ponta, Gϋnter von Minckwitz, Hans‐Peter Sinn, M. Kaufmann, Paul L. Beaumier, Elínborg Ostermann, Horst Ahorn, Erik Patzelt and Günther R. Adolf. Their work appears in journals such as The Lancet, Leukemia, Cancer Immunology Immunotherapy, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026